Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

5.29
+0.04000.76%
Volume:2.72M
Turnover:14.51M
Market Cap:1.04B
PE:-4.91
High:5.48
Open:5.30
Low:5.27
Close:5.25
52wk High:21.73
52wk Low:5.01
Shares:197.00M
Float Shares:94.77M
Volume Ratio:0.90
T/O Rate:2.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0766
EPS(LYR):-1.2118
ROE:-67.42%
ROA:-33.60%
PB:2.30
PE(LYR):-4.37

Loading ...

Wave Life Sciences Director Adrian Rawcliffe Sells 12,700 Shares for $67,183

Reuters
·
Aug 14

Wave Life Sciences Completes Redomiciliation to Delaware from Singapore

Reuters
·
Aug 10

Wave Life Sciences Deregisters Ordinary Shares Under Exchange Act Reporting Rules

Reuters
·
Aug 10

Sarepta Faces Competitive Pressures Despite Pipeline Updates, RBC Says

MT Newswires Live
·
Aug 07

Wave Life Sciences Sets Aug. 7 Completion for Delaware Redomiciliation

Reuters
·
Aug 06

Wave Life Sciences CEO to Speak at BofA Securities SMID Cap Executive Insights Event

Reuters
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 03

Wave Life Sciences Ltd : Bofa Global Research Cuts Price Objective to $17 from $19

THOMSON REUTERS
·
Aug 03

Wave Life Sciences is Maintained at Buy by Citigroup

Dow Jones
·
Aug 01

Analyst Reiterates Buy on Wave’s WVE-007, Maintaining Unchanged $13 Price Target Amid Enhanced Phase 2a INLIGHT Design

TIPRANKS
·
Aug 01

B. Riley Adjusts Wave Life Sciences Price Target to $22 From $31, Maintains Buy Rating

MT Newswires Live
·
Jul 31

Wave Life Sciences Ltd : B. Riley Cuts Target Price to $22 from $31

THOMSON REUTERS
·
Jul 31

Wave Life Sciences price target lowered to $26 from $36 at Clear Street

TIPRANKS
·
Jul 31

WAVE Life Sciences Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Wedbush Adjusts Wave Life Sciences Price Target to $12 From $15, Maintains Outperform Rating

MT Newswires Live
·
Jul 31

Wedbush Releases a Buy Rating on Wave Life Sciences (WVE)

TIPRANKS
·
Jul 30

Earnings Flash (WVE) Wave Life Sciences Posts Q2 Net Loss $0.34 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live
·
Jul 30

Wave Life Sciences Q2 FY26 Net Loss Widens to $69.36 Million; Revenue Drops 73.88% to $2.27 Million

Reuters
·
Jul 30

WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate

Benzinga Earnings
·
Jul 30

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Jul 30